Last reviewed · How we verify

Otosynalar®

Laboratorios Osorio de Moraes Ltda. · Phase 3 active Small molecule

Otosynalar is a topical corticosteroid-antibiotic combination that reduces inflammation and treats bacterial infection in the ear canal.

Otosynalar is a topical corticosteroid-antibiotic combination that reduces inflammation and treats bacterial infection in the ear canal. Used for Acute otitis externa (swimmer's ear), Bacterial infection of the external ear canal with inflammation.

At a glance

Generic nameOtosynalar®
SponsorLaboratorios Osorio de Moraes Ltda.
Drug classTopical corticosteroid-antibiotic combination
ModalitySmall molecule
Therapeutic areaOtolaryngology / Dermatology
PhasePhase 3

Mechanism of action

The formulation combines a corticosteroid (typically neomycin and dexamethasone or similar agents) to suppress inflammatory response and reduce swelling in otitis externa, paired with an antibiotic component to address bacterial infection. This dual action addresses both the infectious and inflammatory components of ear canal disease.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results